Healthcare entity
All 1 tracked stories fall under one category: medical-devices. CooperCompanies is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. They are less corroborated than the beat average, carrying 2 original sources each against 2.8 for the same window.
Last mentioned: Mar 5, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
All 1 tracked stories fall under one category: medical-devices. CooperCompanies is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. They are less corroborated than the beat average, carrying 2 original sources each against 2.8 for the same window. The 5 average consequence score is below the beat benchmark of 5.8 in the same window. We currently track 1 Healthcare story that mention CooperVision, all published on March 5, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 25 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering CooperVision. Shared-story counts are live from our verified record — not editorial picks.
CooperCompanies (NASDAQ: COO) reported fourth-quarter 2025 financial results that met analyst expectations, driven by consistent performance across its CooperVision and CooperSurgical business units. The results underscore the company's resilience in the medical device sector despite broader macroeconomic fluctuations.
Source: markets.financialcontent.com · markets.financialcontent.com
CooperVision is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
